Century Therapeutics Inc (IPSC)
2.96
-0.12
(-3.90%)
USD |
NASDAQ |
May 31, 16:00
2.988
+0.03
(+0.95%)
After-Hours: 20:00
Century Therapeutics Enterprise Value: 53.21M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 53.21M |
| May 30, 2024 | 63.15M |
| May 29, 2024 | 77.24M |
| May 28, 2024 | 81.38M |
| May 24, 2024 | 59.84M |
| May 23, 2024 | 66.47M |
| May 22, 2024 | 81.38M |
| May 21, 2024 | 54.04M |
| May 20, 2024 | 56.53M |
| May 17, 2024 | 57.35M |
| May 16, 2024 | 67.30M |
| May 15, 2024 | 63.98M |
| May 14, 2024 | 68.95M |
| May 13, 2024 | 56.53M |
| May 10, 2024 | 67.30M |
| May 09, 2024 | 59.84M |
| May 08, 2024 | 62.33M |
| May 07, 2024 | 87.18M |
| May 06, 2024 | 70.61M |
| May 03, 2024 | 59.01M |
| May 02, 2024 | 56.53M |
| May 01, 2024 | 59.84M |
| April 30, 2024 | 49.07M |
| April 29, 2024 | 60.67M |
| April 26, 2024 | 46.58M |
| Date | Value |
|---|---|
| April 25, 2024 | 68.95M |
| April 24, 2024 | 53.21M |
| April 23, 2024 | 65.91M |
| April 22, 2024 | 59.32M |
| April 19, 2024 | 62.61M |
| April 18, 2024 | 0.8173M |
| April 17, 2024 | -7.933M |
| April 16, 2024 | 11.51M |
| April 15, 2024 | 45.87M |
| April 12, 2024 | 61.42M |
| April 11, 2024 | 70.50M |
| April 10, 2024 | 53.00M |
| April 09, 2024 | 67.90M |
| April 08, 2024 | 53.00M |
| April 05, 2024 | 43.24M |
| April 04, 2024 | 43.89M |
| April 03, 2024 | 47.78M |
| April 02, 2024 | 53.61M |
| April 01, 2024 | 70.46M |
| March 31, 2024 | 78.89M |
| March 28, 2024 | 98.20M |
| March 27, 2024 | 104.03M |
| March 26, 2024 | 85.24M |
| March 25, 2024 | 87.18M |
| March 22, 2024 | 114.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-104.08M
Minimum
Mar 30 2023
1.366B
Maximum
Aug 11 2021
274.01M
Average
138.63M
Median
Jun 27 2022
Enterprise Value Benchmarks
| Verastem Inc | 52.61M |
| Entero Therapeutics Inc | 72.57M |
| Gritstone Bio Inc | 76.63M |
| Allogene Therapeutics Inc | 135.01M |
| Mirum Pharmaceuticals Inc | 1.138B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -28.06M |
| Revenue (Quarterly) | 0.855M |
| Total Expenses (Quarterly) | 32.16M |
| EPS Diluted (Quarterly) | -0.45 |
| Profit Margin (Quarterly) | -3.28K% |
| Earnings Yield | -74.66% |
| Normalized Earnings Yield | -63.72 |